Strength:
30mg / 5ml
Description:
Multi Dose Vial
Pack Size:
1 Vial
Storage Conditions:
Store between 20° to 25 °C (68° to 77 °F). Protect from light. Retain in carton until use.
Strength:
100mg / 16.7ml
Description:
Multi Dose Vial
Pack Size:
1 Vial
Storage Conditions:
Store between 20° to 25 °C (68° to 77 °F). Protect from light. Retain in carton until use.
Strength:
260mg / 43.4ml
Description:
Multi Dose Vial
Pack Size:
1 Vial
Storage Conditions:
Store between 20° to 25 °C (68° to 77 °F). Protect from light. Retain in carton until use.
Strength:
300mg / 50ml
Description:
Multi Dose Vial
Pack Size:
1 Vial
Storage Conditions:
Store between 20° to 25 °C (68° to 77 °F). Protect from light. Retain in carton until use.
Getwell Pharmaceuticals is a leading manufacturer and supplier of Paclitaxel Injection- Pacliwel at a cost effective price in India. We have a range of complex generics and drug delivery based formulations.
Dosage of Paclitaxel Injection
PACLIWEL should only be administered under the supervision of a qualified oncologist in units specialised in the administration of cyto toxic agents.
The following is a recommended premedication regimen: Dexamethasone (8 - 20 mg) given orally (12 and 6 hours) or intravenously (30 - 60 mins) prior to Paclitaxel, chlorpheniramine 10 mg intravenously or an equivalent antihistamine (30 - 60 mins) before Paclitaxel and cimetidine (300 mg) or ranitidine (50 mg) intravenously (30 - 60 mins) before Paclitaxel.
Side effects of Paclitaxel Injection
Body as a whole: Hypersensitivity reaction, anaphylaxis and anaphylactic shock, angioedema, ataxia, sepsis, chills and fever, asthenia, fever, rigor, headache, paresis, chest pain, fatigue, infusion-related symptoms, peripheral oedema, bone pain, coma, meningitis, cerebral oedema, thinking abnormal, progression of neoplasia.
Digestive: Hepatocellular damage, liver tenderness, diarrhoea, nausea and vomiting, pancreatitis, hepatic failure, jaundice.
Contraindications of Paclitaxel Injection
Pacliwel is contraindicated in patients who have a history of hypersensitivity reactions to paclitaxel or other drugs formulated on polioxy ethylated castor oil.
PACLIWEL should not be used in patients with solid tumours who have baseline 3 neutrophil counts